chr7-113918864-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_002711.4(PPP1R3A):c.133G>A(p.Gly45Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00625 in 1,613,728 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002711.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP1R3A | NM_002711.4 | c.133G>A | p.Gly45Ser | missense_variant | 1/4 | ENST00000284601.4 | NP_002702.2 | |
PPP1R3A | XM_005250473.4 | c.51G>A | p.Glu17Glu | synonymous_variant | 1/5 | XP_005250530.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP1R3A | ENST00000284601.4 | c.133G>A | p.Gly45Ser | missense_variant | 1/4 | 1 | NM_002711.4 | ENSP00000284601.3 | ||
PPP1R3A | ENST00000284602.1 | n.133G>A | non_coding_transcript_exon_variant | 1/5 | 1 | ENSP00000284602.1 | ||||
PPP1R3A | ENST00000449795.5 | c.-181-36544G>A | intron_variant | 3 | ENSP00000401278.1 |
Frequencies
GnomAD3 genomes AF: 0.00592 AC: 900AN: 152016Hom.: 7 Cov.: 32
GnomAD3 exomes AF: 0.00716 AC: 1796AN: 250724Hom.: 16 AF XY: 0.00750 AC XY: 1016AN XY: 135488
GnomAD4 exome AF: 0.00629 AC: 9188AN: 1461594Hom.: 66 Cov.: 31 AF XY: 0.00641 AC XY: 4659AN XY: 727108
GnomAD4 genome AF: 0.00592 AC: 900AN: 152134Hom.: 7 Cov.: 32 AF XY: 0.00682 AC XY: 507AN XY: 74380
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 05, 2018 | - - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Nov 08, 2018 | ACMG criteria: BP4 (6 predictors for BP4, 4 predictors for PP3=not using, REVEL=0.061), BS1 (1.23% in 1000G-SAS, 2.56% in ExAC-Fin), BS2 (112 cases and 105 controls in type2diabetesgenetics.org)=benign - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at